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ABSTRACT 
Objective: The aim of the present work was to prepare film-coated tablet of glucosamine sulfate potassium chloride and study the effect of coating 
process parameters which implicate more significant effects on an aqueous-based film coating process of tablets.  
Methods: The different batches of uncoated tablets were prepared by wet granulation method. Aqueous film coating was carried out by using 
opadry®II white 85F18422. A 32 full factorial design was employed to study the effect of spray rate (X1) and inlet air temperature (X2) on coating 
uniformity, coating process efficiency and % loss on drying. The surface characteristics of the aqueous-based film-coated tablet were studied using a 
SEM. Check point batch was prepared to validate the evolved model. 
Results: Preliminary trials indicated that individual process parameters affected the quality of coated tablets. Hence, studied the combined effect of 
these factors on the coating process required and 32 full factorial design was applied. In this study, it was seen that the spray rate and inlet air 
temperature had a major effect on tablet coating process. It was observed from factorial batch that maximum drug release was found in batch F5. 
Conclusion: The results of full factorial design indicate both parameters spray rate (X1) and inlet air temperature (X2) have a significant effect on 
coating process and batch F5 is stable for 3 mo at the accelerated condition. 
Keywords: Glucosamine sulfate potassium chloride, 32 full factorial design, Aqueous-based film, Spray rate, Inlet air temperature 




Glucosamine sulfate potassium chloride (GS-K) is a naturally 
occurring chemical found in the human body. It resides in human 
cartilage connective tissue that serves as a joint cushion in the 
knees, hips and joints [1, 2]. It is used in the treatment of 
osteoarthritis. GS-K is highly hygroscopic and degrades rapidly 
when exposed to moisture or air. So it’s creating problems in shelf-
life and bioavailability [3, 4].  
Oral route of drug administration is the most appealing route for 
drug delivery. Among the oral dosage form tablet are most preferred 
dosage forms because of its ease to manufacturing, convenience in 
administration and accurate dosing. Film coating and sugar coating 
of the tablets is an additional step in the manufacturing process 
which increases the cost of products [5, 6]. Film coating is carried 
out by using organic solvent or aqueous coating. Aqueous coating of 
oral solid dosage forms has rapidly replaced solvent-based coating 
for safety, environmental and economic reasons. In, aqueous coating 
processing parameters like spray rate, inlet air temperature, pan 
speed, atomizing air pressure are important issues [7, 8]. 
GS-K of orally administered drugs exhibit moisture sensitive 
characteristics that create stability problem in the aqueous coating. 
The slower rate of evaporation gives rise to the possibility of water 
penetrating; this could result in either physical degradation of the 
drug. So, the present work was carried out by optimizing various 
processing parameters and improves the stability and shelf-life of 
the product. 
MATERIALS AND METHODS 
Materials and reagents 
Glucosamine sulfate potassium chloride was received as a generous 
gift from Jenburkt Pharmaceuticals Ltd. Sihor, Gujarat, India. Opadry 
II 85F18422 white was obtained from Colorcon, Goa, India. 
Microcrystalline cellulose (PH 101) and Microcrystalline cellulose 
(PH 102) were purchased from SAVA Fine Chemical, Mumbai, 
Maharashtra, India. All other materials and chemicals used were of 
either pharmaceutical or analytical grade. 
Drug excipients compatibility study 
The physicochemical compatibilities of drug and excipients were 
tested by differential scanning calorimetric (DSC) analysis. DSC 
thermograms of the drug and drug-excipients physical mixtures (1:1 
wt/wt) were derived from a DSC with a thermal analysis performed 
by using an automatic thermal analyzer system (DSC 60, Shimadzu, 
Japan). The analysis was performed at a rate of 10 °C/min from 50 
°C to 250 °C under a nitrogen flow of 20 ml/min [9, 10].  
Development of glucosamine sulfate potassium chloride core tablet 
The tablets were formulated by wet granulation technique and the 
whole process like dispensing; sifting, milling and compression were 
done under the controlled temperature and humidity. All the ingredients 
were individually screened through sieve no. 60, except glidants and 
lubricant. Povidone K30 and methylparaben were dissolved in isopropyl 
alcohol (IPA) which was used as a binder. Dibasic calcium phosphate and 
microcrystalline cellulose (Avicel PH 101) was used as diluents. 
Granulation was carried out in two-liter capacity rapid mixing 
granulator (RMG) and drying was carried out in fluid bed dryer (FBD) 
until LOD was dropped below 2 %. Compression was carried out using 
16 station “D” types tooling rotary compression machine. Composition of 
core formulation described in table 1 [12, 13]. 
Preliminary screening of coating parameters 
GS-K core tablet were coated by using 10% suspension of opadry® II 
85F18422 white in water. Core tablets were loaded into pre-
warmed coating pan. Then spray of the coating dispersion was 
started along with the regulation of various coating parameters like 
atomizing air pressure (1.8 Bar), pan speed (9-11 rpm), spray rate 
and inlet air temperature as described in table 3. Spraying process 
was continued until about 3% weight gain was achieved on the core 
tablets. Then the coated tablets were dried for 15 min at about 50 °C 
of inlet air temperature [14, 15]. 
Evaluation parameters of glucosamine sulfate potassium 
chloride core tablet 
Thickness, Hardness, Weight variation, Drug content uniformity, % 
Friability and Disintegration test of the formulations were measured 
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as described by Yadav K et. al, Khar RK et. al, Madgulkar AR et. al, and Lakade SH et. al, respectively [16-19]. 
 
Table 1: Formulation of glucosamine sulfate potassium chloride core tablet 
Batch No. T1 T2 T3 T4 T5 
Ingredients Quantity (mg/tablet) 
Glucosamine sulfate potassium chloride 750 750 750 750 750 
Microcrystalline cellulose (Avicel PH 101) 187.5 177.5 172.5 162.5 152.5 
Dibasic calcium phosphate (Anhydrous) 100 100 100 100 100 
Methyl paraben 0.5 0.5 0.5 0.5 0.5 
Povidone K30 20 30 35 35 35 
Isopropyl alcohol Q. S. Q. S. Q. S. Q. S. Q. S. 
Sodium starch glycolate 10 10 10 20 30 
Microcrystalline cellulose (Avicel PH 102) 25 25 25 25 25 
Magnesium stearate 7 7 7 7 7 
TOTAL 1100 1100 1100 1100 1100 
 
Evaluation of coating parameters 
Coating uniformity 
The Coating uniformity was measured as the variation in weight 
gain of coated tablets. The reported standard deviation (SD) was 






Where, wtai and wtbi are the weights of tablet i after and before 
coating, respectively, n is the number of tablets measured and x is the 
average weight gain of the n measured tablets from coating [20, 21]. 
% Coating process efficiency 
The % Coating process efficiency (% CPE) will be measured as the 
actual percent weight gain relative to the theoretical percent. 
Coating process efficiency was determined by the following 
equation:  
CPE = % wga
%wgt
× 100 
Where, wgt is the theoretical percent weight gain and wga is the 
actual percent weight gain, before and after coating, respectively 
[22, 23]. 
% Loss on drying  
The % loss on drying (% LOD) is the moisture content of the coated 
tablets expressed as percent weight. The tablets were weighed, 
dried at 60 °C for 24 h and there weighed. %LOD was determined by 
the following equation:  
% LOD =  wtb − wta
wtb
 × 100 
Optimized batch surface roughness was checked by Scanning 
Electronic Microscopy [24, 25]. 
In vitro drug release study 
Drug release studies were carried out by using paddle type 
dissolution test apparatus (50 rpm, 37±0.5 °C) for 45 minute in 
purified water (900 ml). At the end of the time period, 10 ml of the 
samples were withdrawal and analyzed for drug content by using 
HPLC method at 195 nm [26, 27] 
Optimization of aqueous coating process parameters by using 
32 full factorial design 
Two variables, spray rate and inlet air temperature were found 
critical. So, they were optimized using different trials, while other 
parameters were kept constant on the basis of previous coating 
study. On the basis of preliminary results, the coating spray rate (X1) 
and the inlet air temperature (X2) were chosen as independent 
variables in 32 full factorial design, while coating uniformity (CU), 
coating process efficiency (CPE), % loss on drying (%LOD) was 
selected as dependent variables. Multiple linear regression analysis, 
ANOVA and graphical representation of the influence of factor by 3D 
plots were performed using of sigma plot software 11.0. The 
experimental runs and measured responses of 32 full factorial design 
batches of Aqueous Containing of GS-K tablets were depleted in 
table 4 [28-30].  
Stability study of optimized batch 
Optimized batch was packed in blister pack and was placed for 
stability study at 40˚C/75% RH for 3 mo. Samples were evaluated 
after 3-month time for in vitro drug release study. The dissolution 
profile of product was compared using similarity factor, f2, which 














Where, log is logarithm to the base 10, n is the number of time 
points, ∑ is summation over all time points, Rt is the mean 
dissolution value of the reference profile at time t and Tt is the mean 
dissolution value of the test profile at the same time point. The 
USFDA draft guidance document contains more information on 
similarity factor (f2). The value of similarity factor (f2) between 50 
and 100 suggests that the two dissolution profiles are similar [31, 
32]. 
RESULTS AND DISCUSSION 
Drug excipients compatibility study 
The DSC thermograph of the GS-K (fig. 1), mixture (fig. 2) Co-
relatated spectrum of drug and mixture (fig. 3) were obtained. The 
thermograph of pure GS-K showed a melting endothermic peak at 
208.94 °C. The thermograph of excipients showed a melting 
endothermic peak at 209.25 °C. The DSC thermograms of the mixer 
showed sharp distinct endothermic peaks for Glucosamine sulfate 
potassium chloride and the excipients. This indicates that the drug 
did not interact with excipients [33]. 
Evaluation of glucosamine sulfate potassium chloride core 
tablet 
Trial batch of GS-K core tablet showed angle of repose range from 
23.51-27.58, carr’s index range from 6.89-18.75 and hausner’s ratio 
range from 1.07-1.19. All the tablets passed the weight variation test 
and it was found within the pharmacopoeia limits. Hardness of the 
tablets was found to be between 2.56-6.5 kg/cm2. The thickness and 
friability of all the formulation was found to be in the range of 5.2 to 
5.7 mm and 0.35 to 1.2, respectively. Disintegration time of all the 
formulation was found to be between 3.4 to 4.1 min was shown in 
table 2. The core tablets of Batch T1 and T2 failed in hardness and 
friability test. Batch T3 showed good hardness but disintegration 
time was high. Disintegration time was decreased in Batch T4 and 
T5 respectively. So, batch T5 was selected as a final core formulation 
[16-19].
Oza et al. 





Fig. 1: DSC spectrum of glucosamine sulfate potassium chloride 
 
Fig. 2: DSC spectrum of the mixture 
 
 
Fig. 3: DSC Co-related spectrum of drug and mixture 
 
Table 2: Evaluation of glucosamine sulfate potassium chloride core tablet 
Batch T1 T2 T3 T4 T5 
Avg. Weight (mg) 1100±5 1099±2 1099±4 1101±4 1100±3 
Hardness (kg/cm2) 2.56±0.2 4.90±0.3 6.2±0.4 6.4±0.4 6.5±0.6 
Thickness (mm) 5.2±0.1 5.5±0.1 5.4±0.2 5.6±0.1 5.7±0.1 
Friability (%) 1.2-±0.3 0.85-±0.1 0.48±0.4 0.42±0.3 0.35±0.2 
Disintegration Time (min) 4.1±0.4 6.3±0.2 7.7±0.4 5.2±0.5 3.4±0.4 
All values are expressed as mean±SD, n=3 
 
Preliminary screening of coating parameters 
Two variables, spray rate and inlet Air Temperature were found 
critical. So, they were optimized by using different trials, while other 
parameters were kept constant on the basis of previous coating 
study. Spray rate was adjusted 5, 7, 9, 11 and 13 gm/min and the 
batches were designated as B1 to B5 respectively. As shown in table 
2 inlet air temperature was fixed at 50 °C. At a higher spray rate, 
sticking and picking were observed as compared to the lower 
spraying rates. At lower spray, rate coating efficiency was lower 
because the particles are dried between the paths before reaching to 
the tablet bed which also result in the rough surface. Batch B3 gave 
good surface and highest coating process efficiency thus; it was 
decided to use 9 gm/min spray rate in further investigations. For 
batch B6 to B10 inlet air temperature was adjusted 30 °C, 40 °C, 50 
°C, 60 °C and 70 °C respectively. As shown in table 3, Spray rate was 
fixed at 9 gm/min. At 30 °C sticking and picking were observed 
because the water was not evaporated from tablet surface and 
tablets stuck to each other. Nozzle block was observed when inlet air 
temperature was kept 70 °C, maybe because at the higher 
temperature, sprayed particles got dried very quickly. Hence, further 
trials were carried out using combination of inlet air temperature 
(45 °C to 55 °C) and spray rate (7 to 9 gm/min) in order to 
understand their effect and to optimize coating parameters [34, 35]. 
 
Table 3: Preliminary screening of coating parameters 
Batch Inlet air 










B1 50 5 2.1±0.03 72.58±1.2 4 0.42±0.2 + 
B2 50 7 2.3±0.02 80.45±0.4 5 0.53±0.3 + 
B3 50 9 1.8±0.04 86.62±0.8 6 0.76±0.5 + 
B4 50 11 2.2±0.07 79.85±1.7 5 0.87±0.3 + 
B5 50 13 - - - - Sticking and picking 
B6 30 9 - - - - Sticking and picking 
B7 40 9 2.4±0.06 79.63±1.4 6 0.96±0.5 + 
B8 50 9 1.9±0.05 87.56±1.6 7 0.70±0.3 + 
B9 60 9 2.1±0.05 81.35±0.6 5 0.56±0.2 + 
B10 70 9 2.5±0.04 68.75±1.4 5 0.45±0.6 Nozzle block 
All values are expressed as mean±SD, n=3 
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Table 4: Runs and measured responses of 32factorial design of aqueous coating process parameters 
Batch 
code 
Spray rate (X1) Inlet air temperature (X2) Coating uniformity (Y1) Coating process efficiency (Y2) % Loss on drying (Y3) 
F1 -1 -1 1.92 80.42 0.51 
F2 0 -1 2.03 76.26 0.59 
F3 1 -1 2.19 72.86 0.53 
F4 -1 0 1.98 88.29 0.61 
F5 0 0 2.12 86.45 0.7 
F6 1 0 2.27 80.56 0.68 
F7 -1 1 2.11 78.58 0.62 
F8 0 1 2.28 73.65 0.71 
F9 1 1 2.36 70.35 0.69 
Factors and the levels in the design 
Independent variables Low (-1) Medium (0) High (1) 
Spray rate (X1) 7 9 11 
Inlet air temperature (X2) 45 50 55 
 
32 Full factorial design model evaluation 
A statistical model incorporating interactive and polynomial terms 
was used to evaluate the responses:  
Y=b0+b1X1+b2X2+b11X12+b22X22+b12X1X2 
Where, Y is the dependent variable, bo is the arithmetic mean 
response of the 9 runs and any bi is the estimated coefficients for the 
related factor Xi. The main effects (X1 and X2) represent the average 
result of changing one factor at a time from its low to high value. The 
polynomial terms (X12 and X22) are included to investigate 
nonlinearity. The interaction term “X1X2” shows how the response 
changes when the two factors change simultaneously. Evaluation 
data for core tablets and coated tablets were presented in table 5 
and 6 respectively. The fitted equations relating the responses that 
is, coating uniformity (CU), coating process efficiency (CPE) and % 
loss on drying (%LOD) to the transformed factor are shown in table 
4. The polynomial equations can be used to draw conclusions after 
considering the magnitude of coefficient and the mathematical sign 
it carries (i.e. positive or negative). The results of ANOVA suggested 
that F values calculated for CU, CPE and % LOD are 50.980, 55.714 
and 84.632 respectively (table 7). Tabulated F value was found to be 
9.013 at α = 0.05. Calculated F values are greater than tabulated for 
all dependent variables, therefore, factors selected have shown 
significant effects. From the results of multiple regression analysis, it 
was found that all factors had a statistically significant influence on 
all dependent variables as p<0.05 (table 8) [36, 37].  
Full and reduced model for coating uniformity 
The coating uniformity for coated tablets was found to be varied 
from 1.92 to 2.36 and it showed a good correlation coefficient of 
0.988. From the graph (fig. 4) and the regression coefficient values 
of factors, it was concluded that the spray rate gives more effect on 
coating uniformity as compared to inlet air temperature. For coating 
uniformity, the significance levels of the coefficients b11, b22, and b12 
were found to be P = 0.727, 0.804 and 0.268 respectively, so they 
were omitted from the full model to generate a reduced model. The 
P value for variable X1 and X2 were found 0.001 and 0.002 
respectively (P<0.05), which indicate that X1 and X2 both variable 
shown a significant effect on coating uniformity [36, 37]. Hence they 
were retained in the reduced model. The reduced model for coating 
uniformity:  
CU = 2.127+0.135 X1+0.102 X2
 
Table 5: Evaluation of core tablets for factorial batches 
Powder 
blend 
Hardness (kg/cm2) Thickness 
(mm) 
Friability (%) Avg. wt. (mg) Disintegration time (min) 
F1 6.1±0.13 5.7±0.13 0.450±0.2 1100±0.9 3.2±0.5 
F2 6.5±0.21 5.6±0.21 0.448±0.4 1101±0.7 3.3±0.8 
F3 6.0±0.09 6.0±0.09 0.506±0.7 1098±1.1 3.3±0.4 
F4 5.8±.32 5.8±.32 0.656±0.2 1100±1.2 3.4±0.6 
F5 6.4±0.24 5.9±0.24 0.394±0.6 1100±0.9 3.4±0.4 
F6 5.9±0.17 5.7±0.17 0.436±0.3 1102±1.1 3.5±0.6 
F7 5.9±0.27 5.9±0.27 0.353±0.4 1102±0.9 3.5±0.8 
F8 6.4±0.34 5.8±0.34 0.459±0.1 1100±0.8 3.2±0.6 
F9 5.8±0.14 6.1±0.14 0.567±0.5 1101±1.2 3.4±0.4 
All values are expressed as mean±SD, n=3 
 











% Drug release at 45 min 
F1 6.7±0.13 6.3±0.10 1123±0.9 3.5±0.6 81.47±1.6 
F2 7.1±0.21 6.1±0.13 1121±1.1 3.7±0.8 79.12±1.5 
F3 6.9±0.09 6.4±0.12 1124±1.2 3.8±0.5 75.83±0.7 
F4 6.8±0.32 6.1±0.06 1120±0.8 3.2±0.8 82.68±1.5 
F5 7.0±0.24 6.5±0.02 1123±0.6 3.5±0.5 86.24±0.7 
F6 6.9±0.17 6.1±0.14 1118±0.9 3.6±1.0 81.24±1.3 
F7 7.3±0.27 5.8±0.06 1124±1.2 3.4±0.6 79.57±1.2 
F8 7.1±0.34 6.2±0.04 1123±0.8 3.6±0.7 76.82±1.1 
F9 6.9±0.14 6.4±0.07 1122±0.9 3.8±0.4 73.2±1.8 
All values are expressed as mean±SD, n=3 
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Full and reduced model for coating process efficiency 
Coating process efficiency of coated tablets was found to be varied 
from 70.35 to 88.29 and it’s showed good correlation co-efficient of 
0.989. For coating process efficiency, as seen from fig. 5, the 3D plot 
reveled that a corresponding increase spray rate, there were 
decreases in coating process efficiency and corresponding increase 
in inlet air temperature there also decreased the coating process 
efficiency. From regression, it is observed that only X1 and X22 were 
significant model terms which affect the coating process efficiency. 
Interaction and nonlinearity was not observed. The P value for 
variable X1 and X22 were 0.003 and 0.001 (P<0.05), which indicate 
that both variable has a significant effect on the coating process 
efficiency [36, 37]. Hence they were retained in the reduced model. 
The reduced model for Coating process efficiency:  
CPE= 85.284-3.920 X1-9.747 X22
 
Table 7: Analysis of variance (ANOVA) of dependent variable 
Source of variation DF SS MS F value P Value 
CU Dependent variable 
Regression 5 0.173 0.034  
50.980 
 
0.004 Residual 3 0.002 0.0006 
Total 8 0.175 0.021 
CPE Dependent variable 
Regression 5 290.532 58.106  
55.714 
 
0.004 Residual 3 3.129 1.043 
Total 8 293.661 36.708 
% LOD Dependent variable 
Regression 5 0.043 0.008  
84.632 
 
0.002 Residual 3 0.0003 0.0001 
Total 8 0.043 0.005 
 
Table 8: Summary of multiple regression analysis for coating process parameters 
Responses Model Coefficient of regression parameters 
b0 b1 b2 b11 b22 b12 R2 
coating uniformity Full 2.127 0.135 0.102 -0.005 0.005 -0.025 0.988 
Reduced 2.127 0.135 0.102 - - - - 
coating process efficiency Full 85.284 -3.920 –1.160 –0.167 0.277 -9.747 0.989 
Reduced 85.284 -3.920 - - - -9.747 - 
%Loss on drying Full 0.703 0.0267 0.065 0.012 0.060 0.055 0.993 
Reduced 0.703 0.0267 0.065 - 0.060 0.055 - 
 
Full and reduced model for % loss on drying 
The % LOD of coated tablets was found to be varied from 0.51 to 
0.71 and showed good correlation co-efficient of 0.993. For % LOD, 
as seen from fig. 6, the 3D plot reveled that a corresponding increase 
in spray rate, there was increase in % Loss on drying and the 
corresponding increase in inlet air temperature there was also 
increase in the % loss on drying. From regression, it is observed that 
X1, X2, X12 and X22 were significant model terms which affect the % 
loss on drying. Interaction and nonlinearity were not observed. The 
P value for variable X1, X2, X12and X22 were 0.008, 0.001, 0.004 and 
0.005 respectively [36, 37]. Hence they were retained in the reduced 
model. The reduced model for %Loss on drying 
% LOD = 0.703+0.0267 X1+0.0650 X2–0.0600 X12–0.0550 X22. 
Validation of the design 
To validate the evolved mathematical models (reduced models) one 
checkpoint was selected as shown in table 9. Good correlation was 
found between observed and predicted values as shown in table 10. 
Hence, it was concluded that the evolved models may be used for 
theoretical prediction of responses within the factor space [36, 37]. 
Selection of optimized batch in factorial design study 
Drug release of all batches was carried out for 45 min. It was 
observed that (as shown in table no 5) maximum drug release was 
found in batch F5 and other all batches gave less drug release as 
compared to batch F5. Hence, batch F5 was selected as an optimized 
batch. The optimized formulation was subjected to SEM and 
accelerated stability study. 
Stability study of optimized batch  
Short term accelerated stability study showed that there was no 
significant change in the formulation after 3 mo and the evaluation 
result was found within the limit. The results are shown in table 11. 
Batch F5 was kept for the stability study. The in vitro release profile 
at initial and after 3 mo was compared using similarity factor, f2, 
value which was found to be 88.50. There is no significant difference 
in similarity factor, f2, value which indicated that the prepared 
formulation was stable [38]. 
  
Table 9: Formulation of checkpoint batches 
Batch code Variable level 
Coded value Actual value 
X1 X2 X1(mg) X2 (ml) 
CP1 -0.5 -0.5 8 47.5 
 
Table 10: Evaluation of checkpoint batches and comparison with predicted value 
Parameter Actual value Predicted value 
coating uniformity 2.1 2.008 
coating process efficiency 79.23 78.450 
% loss on drying 0.721 0.714 
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Fig. 6: Effect of spray rate (X1) inlet air temperature (X2) on % loss 
on drying. 
 
Fig. 7: SEM of coated tablet surface 
 
Table 11: Comparative study of optimized batch with market product 
S. No. Parameters Initial (Batch F5) After 3 mo (Batch F5) 
1 Hardness (kg/cm2) 7.0±0.21 6.8±0.14 
2 Average weight (mg) 1123±1.3 1121±0.7 
3 Disintegration time (min) 3.5±0.3 3.4±0.4 
4 Assay 99.50±0.4 %w/w 98.90±0.5 %w/w 
5 In vitro drug release (After 45 min.) 86.24±1.5 83.70±1.5 
All values are expressed as mean±SD, n=3 
 
CONCLUSION 
In this study, an aqueous-based film coating process of glucosamine 
sulfate potassium chloride tablets was performed in a side-vented 
perforated pan coating apparatus (auto coater). The preliminary 
results revealed that spray rate, and inlet air temperature had a major 
effect on tablet coating performances. The spray rate of coating 
solution 9 gm/min and inlet air temperature 50 °C considered as an 
optimum aqueous film coating of special shaped tablets in auto coater 
coating machine. An optimized batch was found stable. It showed that 
aqueous based film coating process is compatible with the drug. 
Moreover, the process of film coating in developed formulation is eco-
friendly, non-hazardous and cost-effective. 
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